Clinical Trial Update: A 19-week Cognition Study of Levetiracetam in Children With Partial Onset Seizures [Phase 2]

View source ↗

Summary

A Phase 2 cognition study of levetiracetam in children with partial-onset seizures has completed (19-week evaluation).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Partial-onset Seizures

Drugs mentioned

• Levetiracetam (Keppra) (levetiracetam)

Snippet

Sponsor: UCB Pharma | Conditions: Epilepsy, Partial | Phase 2 | Status: COMPLETED